This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: National Cancer Center. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Yohei Hisata in Antibody Development
Introduction
Yohei Hisata is a notable inventor based in Kashiwa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins. His work is crucial for advancements in medical research and treatment.
Latest Patents
His most recent patent is titled "Antibody against insoluble fibrin." This invention aims to provide an antibody that does not bind to fibrinogen while exhibiting high affinity and specificity for insoluble fibrin. His research identified critical binding sites within the fibrinogen molecule, which become exposed when fibrinogen is converted to insoluble fibrin. The antibodies developed through this research do not interact with fibrinogen, making them highly effective for targeted applications.
Career Highlights
Yohei Hisata is currently affiliated with the National Cancer Center, where he continues to advance his research in antibody development. His innovative approach has the potential to impact cancer treatment and diagnostics significantly.
Collaborations
He has collaborated with esteemed colleagues such as Yasuhiro Matsumura and Masahiro Yasunaga, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yohei Hisata's work in developing specific antibodies represents a significant advancement in biotechnology. His contributions are poised to enhance medical research and treatment options in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile